G

Glycostem Therapeutics

39 employees

Glycostem is a clinical stage biotech company developing off-the shelf allogeneic cellular immunotherapy using Natural Killer (NK) cells.

Basic info

Industry

biotechnology research

Sectors

Pharmaceutical

Biotechnology

Life Science

Date founded

2007

FAQ